LLVK is a selective IkappaB phosphorylation inhibitor. LLVK reduces LPS-induced pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alpha). LLVK is promising for research of inflammatory bowel disease and rheumatoid arthritis[1].
Molecular Weight:
471.63
CAS Number:
[798540-36-0]
Formula:
C23H45N5O5
Target:
IKK,NF-kappaB
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
